SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  
 
Database maintenance is being performed.  If something doesn’t work, please try again shortly.

Hologic Inc · 8-K · For 6/28/01 · EX-99

Filed On 6/28/01 2:01pm ET   ·   SEC File 0-18281   ·   Accession Number 927016-1-501710

  in   Show  and 
Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs: (and), (or);  for Text: (anywhere),  "(&)" (near).
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

 6/28/01  Hologic Inc                       8-K{5,7}    6/28/01    2:3                                      Donnelley R R & S..07/FA

Current Report   ·   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         2      9K 
 2: EX-99       Press Release                                          1      8K 


EX-99   ·   Press Release

EX-99TOCTopPreviousNextBottomJust 1st
 
Sponsored Ads...

Exhibit 99 NEWS RELEASE FOR IMMEDIATE RELEASE Contact: Glenn P. Muir Marianne E. Ritchie Executive Vice President, Finance Manager, Investor Relations Hologic, Inc. Hologic, Inc. (781) 999-7300 (781) 999-7300 HOLOGIC REGRETFULLY ANNOUNCES PASSING OF S. DAVID ELLENBOGEN, ITS CHAIRMAN AND CEO COFOUNDER AND EXECUTIVE VICE PRESIDENT, JAY A. STEIN, APPOINTED CHAIRMAN AND INTERIM CEO BEDFORD, Mass., (June 22, 2001) -- Hologic, Inc. (NASDAQ: HOLX), a leading provider of a broad array of radiographic equipment, regretfully announces that S. David Ellenbogen, its Chairman and Chief Executive Officer, passed away unexpectedly early Thursday morning, June 21, as a consequence of heart failure. Jay A. Stein, Executive Vice President and Chief Technical Officer, has been appointed Chairman and has agreed to serve as interim Chief Executive Officer. The Board of Directors of the Company has authorized a search to fill the Chief Executive Officer position on a permanent basis. Mr. Ellenbogen was a cofounder of the Company and served as its Chief Executive Officer and Chairman since its formation in October 1985. "We have all suffered a great loss with the passing of Dave Ellenbogen," said Jay Stein, cofounder, partner and long-time friend. "Dave was a well-known, well-respected veteran of the medical device industry. He was a true visionary who knew every aspect of the industry from business development and financing to production and global expansion. Perhaps Dave's strongest asset was his ability to motivate those around him to new levels of greatness. Dave took great pride in the companies he helped to create. However, he felt his greatest achievement was his family. Our deepest sympathies go out to his wife Elaine, and his children Sandy and Michael and their families. His strong leadership qualities, his creativity, his entrepreneurial spirit, and great sense of humor will be deeply missed." "We are greatly saddened by the death of our fellow director and friend," said Gerald Segel, a member of the Company's Board of Directors. "However, we feel we are fortunate that David has been able to attract and retain a strong and experienced management team. This team has worked closely with David over the past year in developing the Company's long-term goals and business strategies following the Company's recent acquisitions. We are confident that this team has the vision and experience to implement and adapt these strategies in today's marketplace." ###

Dates Referenced Herein   and   Documents Incorporated By Reference

This 8-K Filing   Date   Other Filings
6/22/01
Filed On / Filed As Of / For The Period Ended6/28/01
 
TopList All Filings


Filing Submission   -   Alternative Formats (Word / Rich Text, HTML, Plain Text, SGML, XML, et al.)
Sponsored Ads...

Copyright © 2009 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun, 8 Nov 08:21:36.0 GMT